Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure

This publication has 16 references indexed in Scilit:

• Myeloperoxidase-Generated Oxidants Modulate Left Ventricular Remodeling but Not Infarct Size After Myocardial Infarction
  Circulation, 2005
• Myeloperoxidase and Cardiovascular Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Preliminary Evaluation of the AxSYM B-Type Natriuretic Peptide (BNP) Assay and Comparison with the ADVIA Centaur BNP Assay
  Clinical Chemistry, 2004
• Prognostic Value of Myeloperoxidase in Patients with Chest Pain
  New England Journal of Medicine, 2003
• Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction
  The Journal of Experimental Medicine, 2003
• Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of Inflammation
  Journal of Biological Chemistry, 2002
• Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
  JAMA, 2001
• Nitric oxide synthase activity in peripheral polymorphonuclear leukocytes in patients with chronic congestive heart failure
  The American Journal of Cardiology, 2001
• Formation of Nitric Oxide–Derived Oxidants by Myeloperoxidase in Monocytes
  Circulation Research, 1999
• Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-α
  Published by Oxford University Press (OUP) ,1999